MeSH tree: C19.053
A common but often overlooked cause of high blood pressure may be hiding in plain sight—and data from a pioneering wearable device could hold the key to its earlier diagnosis, according to new research.
Aug 26, 2026
0
13
A simple new method based on the results of two studies from Christofer Juhlin's research group can make it easier to identify the underlying cause of a common form of high blood pressure and help predict who will benefit ...
Aug 18, 2026
0
5
I teach a university course called Hormones and Behaviour. What surprises students is that biological sex is not produced by a single switch. What surprises me is that many students have never been taught this before. It ...
Aug 14, 2026
0
8
Primary aldosteronism (otherwise known as PA or Conn Syndrome) is the leading endocrine cause of hypertension (high blood pressure). It carries a higher risk of stroke, heart attack, atrial fibrillation and kidney failure ...
Aug 11, 2026
0
5
Your social media feed is full of people talking about the "holy grail" of skincare.
Jul 30, 2026
0
7
A pilot study from Karolinska Institutet shows that immunotherapy may enable the stimulation of egg maturation in women with autoimmune POI (premature ovarian insufficiency)—a condition that usually leads to infertility. ...
Jun 24, 2026
0
6
A study of a new AI model examining 30 years of routine electronic health records (EHR) data could improve screening for primary aldosteronism, a leading cause of high blood pressure that is often unrecognized but increases ...
Jun 13, 2026
0
7
Researchers at Trinity have found that a largely overlooked form of cancer evolution, which drives aggressive disease and poor patient outcomes, is far more widespread than previously thought. Comparing chromosome patterns ...
Jun 2, 2026
0
5
A new first-in-human study has validated a PET radiotracer that can effectively image overactive adrenal glands, offering an alternative to the highly invasive procedure currently utilized to diagnose primary aldosteronism. ...
Jun 1, 2026
0
3
The U.S. Supreme Court has preserved access to mifepristone—the medication used in the majority of abortions in the United States and in some miscarriage care—for now. The action maintains current rules that allow certified ...
May 18, 2026
0
4
